Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Should You Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares gapped up before the market opened on Monday . The stock had previously closed at $9.38, but opened at $10.5101. Ambu A/S shares last traded at $10.5101, with a volume of 102 shares trading hands.

Ambu A/S Trading Up 8.4%

The company has a market capitalization of $2.47 billion, a P/E ratio of 37.54 and a beta of 1.01. The stock’s 50 day moving average is $9.78 and its 200-day moving average is $11.23. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.The business had revenue of $246.39 million for the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.